7 completed, 4 unknown, 1 terminated. 12 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 7, Unknown 4, Terminated 1 |
| Phase 2 | 3 | Unknown 2, Terminated 1 |
Follow Chronic Renal Failure: new trials by email Literature Review of Chronic Renal Failure trials Research Report on Chronic Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers CKD-349 F1 Tab., CKD-349 F2 Tab., D113 Tab. - Chronic Renal Failure | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 25 | 2021-07-19 | 2024-01-24 |
| MSC and Kidney Transplant Tolerance (Phase A) Mesenchymal Stromal Cells - Chronic Renal Failure | Phase 1 | Unknown | Monia Lorini | 22 | 2015-09-01 | 2018-04-06 |
| rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics Recombinant erythropoietin stimulating protein - Chronic Renal Failure | Phase 1 | Unknown | Shenyang Sunshine Pharmaceutical Co., LTD. | 40 | 2014-09-01 | 2015-02-05 |
| Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure Intravenous transfer of Autologous (BMMNCs) - Chronic Renal Failure | Phase 1 / Phase 2 | Unknown | Chaitanya Hospital, Pune | 15 | 2014-09-01 | 2014-09-17 |
| Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease Intravenous injection autologous mesenchymal stem cells - Chronic Renal Failure, Polycystic Kidney Disease | Phase 1 | Completed | Royan Institute | 6 | 2014-03-01 | 2016-01-05 |
| A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment Epoetin Hospira, Epogen - Chronic Renal Failure | Phase 1 | Completed | Hospira, now a wholly owned subsidiary of Pfizer | 107 | 2010-07-01 | 2017-03-20 |
| Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure Autologous bone marrow stem cells - Chronic Renal Failure | Phase 1 / Phase 2 | Unknown | International Stemcell Services Limited | 5 | 2010-02-01 | 2012-03-29 |
| Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects CTAP101 Capsules, CTAP101 Injection - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 1 | Completed | OPKO IP Holdings II, Inc. | 28 | 2009-05-01 | 2014-09-30 |
| Safety Study of TRK-820 for Patient With Hemodialysis nalfurafine hydrochloride - Chronic Renal Failure | Phase 1 | Completed | SK Chemicals Co., Ltd. | 16 | 2008-12-01 | 2010-11-25 |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) CTAP201 Injection, Doxercalciferol - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 1 | Completed | OPKO IP Holdings II, Inc. | 24 | 2008-11-01 | 2014-09-29 |
| Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers Placebo, peginesatide - Anemia, Chronic Kidney Disease | Phase 1 | Completed | Affymax | 28 | 2004-08-01 | 2012-12-21 |
| Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis edifoligide (E2F Decoy) - Hyperplasia, Chronic Renal Failure | Phase 1 / Phase 2 | Terminated | Anesiva, Inc. | 2004-05-01 | 2005-07-19 |
Kidney Failure, Chronic (12) · Renal Insufficiency, Chronic (4) · Renal Insufficiency (3) · Hyperparathyroidism (2) · Hyperparathyroidism, Secondary (2) · Kidney Diseases (2) · Parathyroid Diseases (2) · Anemia (1) · Hyperplasia (1) · Neoplasms (1) · Polycystic Kidney Diseases (1)
Chronic Disease (12) · Disease Attributes (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Male Urogenital Diseases (12) · Pathologic Processes (12) · Pathological Conditions, Signs and Symptoms (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Kidney Diseases (10) · Renal Insufficiency (9) · Renal Insufficiency, Chronic (8) · Endocrine System Diseases (2) · Abnormalities, Multiple (1) · Ciliopathies (1)
1 alpha-hydroxyergocalciferol (1) · Epoetin Alfa (1) · TRK 820 (1) · edifoligide (1) · hematide (1) · peginesatide (1)
OPKO IP Holdings II, Inc. (2) · Affymax (1) · Anesiva, Inc. (1) · Chaitanya Hospital, Pune (1) · Chong Kun Dang Pharmaceutical (1) · Hospira, now a wholly owned subsidiary of Pfizer (1) · International Stemcell Services Limited (1) · Monia Lorini (1) · Royan Institute (1) · SK Chemicals Co., Ltd. (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1)
United States (4) · India (2) · South Korea (2) · China (1) · Iran (1) · Italy (1) · United Kingdom (1)
Joel Melnick, MD (2) · Alessandro Rambaldi, MD (1) · Atieh Makhlough, MD (1) · Balakrishna S, M.B.B.S (1) · Federica Casiraghi (1) · Giovanni Rota, MD (1) · Giuseppe Remuzzi, MD (1) · Hamid Gourabi, PhD (1) · Jang Hee Hong (1) · Limei Zhao, doctor (1) · Martino Introna, MD (1) · Nasser Aghdami, MD,PhD (1) · Norberto Perico, MD (1)
2004 (1), 2015 (1)